Subclassification of left ventricular hypertrophy based on dilation stratifies coronary artery disease patients with

Bao-Tao Huang1, Yong Peng, Wei Liu

  • 1Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.

Insights

Dilated left ventricular hypertrophy (LVH) in coronary artery disease (CAD) patients indicates worse outcomes. Eccentric dilated LVH showed the highest risk for death and composite events, while eccentric nondilated LVH did not predict adverse events.

Area of Science:

  • Cardiology
  • Echocardiography
  • Clinical Outcomes

Background:

  • A novel 4-tiered classification for left ventricular hypertrophy (LVH) categorizes geometry by concentricity and dilation.
  • The prognostic implications of this LVH classification in patients with coronary artery disease (CAD) remain unclear.

Purpose of the Study:

  • To investigate the association between LV geometry patterns and clinical outcomes in patients with CAD.
  • To determine if the new LVH classification provides distinct prognostic information.

Main Methods:

  • Echocardiographic assessment of left ventricular mass (LVM) and end-diastolic volume (EDV) in 2297 CAD patients.
  • Classification of LV geometry into five groups: eccentric nondilated LVH, eccentric dilated LVH, concentric nondilated LVH, concentric dilated LVH, and normal LV mass.
  • Analysis of all-cause death and composite events using Cox regression.

Main Results:

  • Dilated LVH (both eccentric and concentric) was associated with significantly higher rates of all-cause death and composite events compared to nondilated LVH.
  • Eccentric dilated LVH demonstrated the highest risk for all-cause death (aHR 2.752) and composite events (aHR 2.462).
  • Eccentric nondilated LVH showed comparable risks for adverse outcomes to normal LV mass.

Conclusions:

  • LVH geometry, specifically dilation, provides significant and distinct prognostic information in patients with CAD.
  • Eccentric nondilated LVH is not associated with adverse outcomes.
  • The classification aids in risk stratification for CAD patients with LVH.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
861
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
811
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
785
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.1K